Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.
about
Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck CancerThe prognostic significance of lymphatics in colorectal liver metastasesThe kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.
P2860
Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment with the vascular di ...... sition in the surviving tumor.
@en
Treatment with the vascular di ...... sition in the surviving tumor.
@nl
type
label
Treatment with the vascular di ...... sition in the surviving tumor.
@en
Treatment with the vascular di ...... sition in the surviving tumor.
@nl
prefLabel
Treatment with the vascular di ...... sition in the surviving tumor.
@en
Treatment with the vascular di ...... sition in the surviving tumor.
@nl
P2093
P2860
P50
P356
P1433
P1476
Treatment with the vascular di ...... nsition in the surviving tumor
@en
P2093
Cathy Malcontenti-Wilson
Jurstine Daruwalla
Lie Sam Chan
Linh Nguyen
Mark Waltham
Patricia Luiza Nunes Costa
Theodora Fifis
P2860
P304
P356
10.1002/CAM4.109
P407
P577
2013-08-18T00:00:00Z